Fradafiban

Drug Profile

Fradafiban

Alternative Names: BIBU 52; BIBU 52 ZW

Latest Information Update: 13 Jun 2001

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Boehringer Ingelheim Pharma KG
  • Class Antiplatelets; Biphenyl compounds; Pyrrolidines; Small molecules
  • Mechanism of Action Fibrinogen receptor antagonists; GPIIb-IIIa antagonists; Platelet aggregation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Thrombosis; Unstable angina pectoris

Most Recent Events

  • 13 Jun 2001 Discontinued-II for Thrombosis in Europe (IV)
  • 13 Jun 2001 Discontinued-II for Unstable angina pectoris in Europe (IV)
  • 13 Jun 2001 Discontinued-II for Unstable angina pectoris in USA (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top